Nephros, Inc.
NEPH
$3.58
$0.113.17%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 776.00K | 1.19M | 1.48M | 1.33M | 801.00K |
| Total Depreciation and Amortization | 126.00K | 139.00K | 142.00K | 141.00K | 143.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 694.00K | 725.00K | 822.00K | 845.00K | 847.00K |
| Change in Net Operating Assets | -1.94M | -413.00K | 274.00K | -316.00K | -1.29M |
| Cash from Operations | -348.00K | 1.65M | 2.72M | 2.00M | 502.00K |
| Capital Expenditure | -- | -- | 0.00 | 0.00 | -55.00K |
| Sale of Property, Plant, and Equipment | -- | -- | 0.00 | 0.00 | 5.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 0.00 | 0.00 | -50.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -5.00K | -5.00K | -5.00K | -3.00K | -4.00K |
| Issuance of Common Stock | 290.00K | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 285.00K | -5.00K | -5.00K | -3.00K | -4.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -63.00K | 1.64M | 2.71M | 1.99M | 448.00K |